With key issues not quite yet in the rearview mirror, steering clear of NIO stock continues to be best move to make. More
Articles
Good News, LLY Stock Invetors! Eli Lilly Is Poised for a Promising 2023.
LLY stock investors were winners in 2022, and Eli Lilly's expanding pipeline points to possible further gains for patient shareholders. More
The Market Is Charging Ahead
And we have the best way to play it. More
This Megatrend Is Entering a Fast and Furious New Phase
Some trends are too cool (and too profitable) to end. More
GDP Surprise Strength
Positive news from the GDP and Tesla … are earnings forecasts delusional? … weakening consumer health … all eyes on next Wednesday Score one for the “soft landing” narrative.This morning, we learned that Q4 GDP topped estimates, climbing at a 2.9% annualized pace, compared to the expectation of 2.8%.Consumer spending, accounting for roughly 68% of… More